Heart Rate Variability modifications induced by high doses of IncobotulinumtoxinA and OnabotulinumtoxinA in hemiplegic chronic stroke patients: A single blind randomized controlled, crossover pilot study.

CONCLUSIONS: Our data show that high doses (>600 U) of incobotulinumtoxinA and onabotulinumtoxinA do not influence the cardiovascular activity of the autonomic nervous system in chronic hemiplegic spastic stroke survivors. PMID: 28877510 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28877510?dopt=Abstract

Source: Toxicon - September 3, 2017 Category: Toxicology Authors: Baricich A, Grana E, Carda S, Santamato A, Molinari C, Cisari C, Invernizzi M Tags: Toxicon Source Type: research